1. Fiocchi, C. Inflammatory bowel disease: aetiology and pathogenesis. Gastroenterology 115, 182–205 (1998).
2. REMICADE® (infliximab) for injection. Prescribing information ( Malvern, P. C., Inc., 2008).
3. HUMIRA® (adalimumab). Prescribing information (Abbott Laboratories, 2008).
4. Cimzia® (certolizumab pegol). Prescribing information ( Smyrna, G. U., Inc., 2008).
5. Tysabri® (natalizumab). Prescribing information (Elan Pharmaceuticals, 2008).